Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial

Journal of Urology

Volumn 195, Issue 2, 2016, Pages 385-390

  Sivalingam, Sri ^a   Streeper, Necole M ^b   Sehgal, Priyanka D ^c   Sninsky, Brian C ^c   Best, Sara L ^c   Nakada, Stephen Y ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

nephrolithiasis; stents; tamsulosin; tolterodine; ureter

Indexed keywords

TAMSULOSIN; TOLTERODINE; SULFONAMIDE; URINARY TRACT AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASTHENIA; BODY MASS; CONSTIPATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; FEMALE; HEADACHE; HUMAN; KIDNEY COLIC; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; MONOTHERAPY; NOSE OBSTRUCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROGRADE EJACULATION; SEXUAL BEHAVIOR; STENT MIGRATION; STOMACH PARESIS; TRANSITIONAL CELL CARCINOMA; TREATMENT DURATION; URETER DISEASE; URETER STENT; URETERAL STENT DISCOMFORT; URINARY TRACT INFECTION; URINE RETENTION; XEROPHTHALMIA; XEROSTOMIA; ADVERSE EFFECTS; ANALGESIA; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; PAIN MEASUREMENT; PROCEDURES; QUALITY OF LIFE; QUESTIONNAIRE; STENT; URETER;

ACTIVITIES OF DAILY LIVING; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MANAGEMENT; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; STENTS; SULFONAMIDES; SURVEYS AND QUESTIONNAIRES; TOLTERODINE TARTRATE; URETER; UROLOGICAL AGENTS;

EID: 84953807238     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.08.104     Document Type: Article

References (22)

1. H.B. Joshi, N. Newns, A. Stainthorpe, and et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure J Urol 169 2003 1060
2. J.E. Lingeman, G.M. Preminger, E.R. Goldfischer, and et al. Assessing the impact of ureteral stent design on patient comfort J Urol 181 2009 2581
3. A.E. Krambeck, R.S. Walsh, J.D. Denstedt, and et al. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent J Urol 183 2010 1037
4. R. Damiano, R. Autorino, M. De Sio, and et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study J Endourol 22 2008 651
5. A.E. Dellis, F.X. Keeley, V. Manolas, and et al. Role of α-blockers in the treatment of stent-related symptoms: a prospective randomized control study Urology 83 2014 56
6. S. Sivalingam, and M. Monga Management of ureteral stent discomfort in contemporary urology practice Urol Pract 1 2014 141
7. S.C. Park, S.W. Jung, J.W. Lee, and et al. The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms J Endourol 23 2009 1913
8. S.J. Lee, C. Yoo, C.Y. Oh, and et al. Stent position is more important than α-blockers or anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic ureterolithotomy: a prospective randomized study Korean J Urol 51 2010 636
9. K.T. Lim, Y.T. Kim, T.Y. Lee, and et al. Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts Korean J Urol 52 2011 485
10. H. Lepor Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group Urology 51 1998 892
11. N. Brynne, M.M. Stahl, B. Hallén, and et al. Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity Int J Clin Pharmacol Ther 35 1997 287
12. R. Yakoubi, M. Lemdani, M. Monga, and et al. Is there a rule for α-blockers in ureteral stent related symptoms? A systematic review and meta-analysis J Urol 186 2011 928
13. R. Damiano, A. Oliva, C. Esposito, and et al. Early and late complications of double pigtail ureteral stent Urol Int 69 2002 136
14. R.J. Lang, M.E. Davidson, and B. Exintaris Pyeloureteral motility and ureteral peristalsis: essential role of sensory nerves and endogenous prostaglandins Exp Physiol 87 2002 129
15. C.J. Wang, S.W. Huang, and C.H. Chang Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study Urol Int 83 2009 66
16. C. Deliveliotis, M. Chrisofos, E. Gougousis, and et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 67 2006 35
17. R. Beddingfield, R.N. Pedro, B. Hinck, and et al. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study J Urol 181 2009 170
18. C.J. Wang, S.W. Huang, and C.H. Chang Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study Urol Res 37 2009 147
19. R.D. Norris, R.L. Sur, W.P. Springhart, and et al. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort Urology 71 2008 792
20. Y.J. Lee, K.H. Huang, H.J. Yang, and et al. Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy Urolithiasis 41 2013 247
21. E. Shalaby, A.F. Ahmed, A. Maarouf, and et al. Randomized controlled trial to compare the safety and efficacy of tamsulosin, solifenacin, and combination of both in treatment of double-J stent-related lower urinary symptoms Adv Urol 2013 2013 752382
22. A. Tehranchi, Y. Rezaei, H. Khalkhali, and et al. Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial Int Braz J Urol 39 2013 832